Document Detail


Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
MedLine Citation:
PMID:  22257295     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Sialylation of the N-linked glycan on asparagine-297 within the Fc region of intravenous gammaglobulins (IVIgs) was shown to be necessary for efficacy of IVIg in the amelioration of experimental inflammatory arthritis. To test the role for Fc sialylation of IVIg in immune modulating therapies beyond the K/BxN arthritis model, we examined the efficacy of sialylated compared to nonsialylated IVIg for the ability to attenuate immune thrombocytopenia (ITP) in a mouse model that approximates the clinical setting of human ITP. STUDY DESIGN AND METHODS: We used a published, passive anti-platelet (PLT) dose-escalation mouse model of ITP that approximates clinical ITP. PLT counts were followed over time before and after IVIg treatment. IVIg from two different manufacturers was used to prepare untreated and neuraminidase-treated IVIg. Sambucus nigra agglutinin (SNA) affinity chromatography was used to obtain sialic acid-enriched and -depleted IVIg. Sialic acid content was determined using Western blot, enzyme-linked immunosorbent assay, and high-performance liquid chromatography. RESULTS: Results were the same using sialylated and desialylated (neuraminidase-treated) IVIg from two different manufacturers. No differences were observed between sialic acid-enriched and -depleted IVIg compared to normal IVIg in their efficacy to alleviate ITP. Using quantitative reverse transcription-polymerase chain reaction, no increase in the spleen FcγRIIB mRNA was detectable, but a pronounced increase of FcγRIIB mRNA in the marrow was seen after IVIg administration. CONCLUSIONS: We conclude that IVIg ameliorates experimental ITP by a mechanism that is independent of sialylation either in the Fc or the Fab region of IVIg.
Authors:
Danila Leontyev; Yulia Katsman; Xue-Zhong Ma; Sylvia Miescher; Fabian Käsermann; Donald R Branch
Related Documents :
2137285 - Ceramic bracket bonding: a comparison of bond strength with polyacrylic acid and phosph...
2207225 - Adhesion of carboxylate cements to hydroxyapatite. iii. adsorption of poly(alkenoic aci...
9477025 - Analytical and ultrastructural studies of pellicle on primary teeth.
16921535 - Thermal degradation of environmentally degradable poly(hydroxyalkanoic acid)s.
24292125 - Recent advances in production of succinic acid from lignocellulosic biomass.
22062645 - Influence of genetic type, live weight at slaughter and carcass fatness on fatty acid c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-18
Journal Detail:
Title:  Transfusion     Volume:  -     ISSN:  1537-2995     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-1-19     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0417360     Medline TA:  Transfusion     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 American Association of Blood Banks.
Affiliation:
From Research & Development, Canadian Blood Services, Immunology Hub, Toronto Centre, and the Department of Medicine, University of Toronto, Toronto, Ontario, Canada; Research & Development, CSL Behring, Bern, Switzerland; and the Division of Cell & Molecular Biology, Toronto General Research Institute, Toronto, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Congenital diaphragmatic defects: proposal for a new classification based on observations in 234 pat...
Next Document:  Novel Vancomycin-Resistance Transposon, Plasmid Replicon Types, and Virulence Factors of Vancomycin-...